CATHRYN WLODYKA: Open Payments
NPI 1669102893 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,695 in 194 payments from 21 companies in 2025. Trend: 2023 $4,032 · 2024 $5,012 · 2025 $3,695
Food & beverage: $3,567Education: $129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $1,165 |
| Janssen Biotech, Inc. | 16 | $433 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 38 | $404 |
| Aimmune Therapeutics, Inc. | 9 | $235 |
| VIVUS LLC | 11 | $227 |
| QOL Medical, LLC | 12 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $199 |
| Ardelyx, Inc. | 10 | $151 |
| Lilly USA, LLC | 5 | $114 |
| Madrigal Pharmaceuticals | 4 | $109 |
Products named: TREMFYA, XIFAXAN, SKYRIZI, RINVOQ, ZENPEP, PANCREAZE, Sucraid, CREON.
Industry payments across NC — which companies pay providers there.
